The Federal Trade Commission (FTC) has released its 2024 Annual Report on Refunds to Consumers, showcasing $337.3 million ...
The introduction of biosimilars in the treatment of age-related macular degeneration (AMD) is raising concerns among physicians about cost-driven mandates and the autonomy to choose the best therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results